Top Markets
Coin of the day
Clearbridge Health Limited Clearbridge Health Limited

Clearbridge Health Limited

1H3
Rang in aandelen #32403
Established in 2010 and headquartered in Singapore, Clearbridge Health Limited... Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's activities are organized into three key divisions: Strategic Investments, Healthcare Systems, and Medical Clinics/Centres. Its extensive range of services encompasses advanced imaging diagnostics, such as general X-ray, CT scans (including dental cone beam), mammography, MRI, and ultrasound. Furthermore, Clearbridge offers general wellness screenings for conditions like diabetes, high blood pressure, and elevated cholesterol, alongside vaccination programs. Specialized care includes renal treatment, clinical services, aesthetic procedures, and dental and orthodontic services. Beyond patient care, the company provides consultancy to healthcare organizations and is involved in the wholesale supply of medicinal and pharmaceutical products.
Aandeelprijs
$0.00158262
Laatst gesynchroniseerd: 2026-08-17
Marktkapitalisatie
$10.20M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-
Land
SG
Handel Clearbridge Health Limited (1H3)

Categorie

Winst voor Clearbridge Health Limited (1H3)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Clearbridge Health Limited bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Clearbridge Health Limited van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US